HK2 and breast neoplasm: Of note, circKIF4A has been recently demonstrated to reprogram breast tumor glucose metabolism by sponging miR-335, which in turn modulates the expression of the OCT4/ALDOA (aldolase A)-HK2 (hexokinase 2)/PKM2 (pyruvate kinase M2) axis [134].